Optimizing nutrition, diet, and lifestyle communication in GLP-1 medication therapy for weight management: A qualitative research study with registered dietitians
David Despain, Brenda L. Hoffman
Abstract
This qualitative study used semi-structured interviews to examine registered dietitians’ perspectives on diet, nutrition, and lifestyle communication for patients on GLP-1 medications for obesity management. Through in-depth interviews with registered dietitians, this research identifies elements that could improve both the efficacy of GLP-1 medication therapies and patient adherence. Results indicate that a comprehensive approach, integrating patient communication with proactive management of side effects and ongoing lifestyle counseling, is essential for optimizing treatment outcomes. Key findings include the importance of using visual and metaphorical aids to improve understanding, the necessity for structured lifestyle programs, and the pivotal role of personalized diet plans. These insights offer valuable directions for enhancing patient care and formulating clinical practices around the use of GLP-1 receptor agonist medications. • This study used semi-structured interviews with registered dietitians to examine their perspectives on diet and lifestyle education for patients on GLP-1 medications for obesity management. • The study highlights the need for improved communication strategies and managing expectations for patients using GLP-1 medications. • Proactive management of appetite suppression and gastrointestinal adverse effects, including advice on dietary adjustments (e.g. small frequent meals), makes it easier to continue medication and prevent nutritional deficiencies. • Tailored nutritional plans based on individual patient needs and preferences can help promote long-term weight maintenance and improved health outcomes. • Addressing mental health and body image concerns, such as weight stigma, through comprehensive care that includes psychological support, helps patients build sustainable healthy habits alongside GLP-1 medication.